Needham analyst James Ricchiuti lowered his price target on II-VI (IIVI) to $48 after its announced acquisition of Finisar (FNSR) on Friday. The analyst points to the 19% decline in its stock price, saying the investor concerns are understandable given the risks involved with "integrating a low-margin business that has clearly struggled over the years." Richiutti keeps his Buy rating on II-VI however, noting that the reaction is likely overdone, while also giving its management the "benefit of a doubt" in being able to generate "solid earnings accretion" from the deal 12 months after the close.